Moreover, SCLC-P tumors showed a trend for OS benefit in the combination ICB arm (EP + Atezo 9.6 mo vs.
also in 53,322 other papers
Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.